About Abelia
Abelia was a Healthcare company based in Delhi (India) founded in 2021. It delivers validation, auditing, and consulting services tailored to the biopharma sector. It operates on a B2B model. Its Indian entity Abelia Life Sciences Private Limited reported revenue of ₹4.1 Lakh. The company is recorded as dissolved. Its focus areas include Biopharma Services, Consulting and Auditing and Validation. Its competitors include Indegene, Zuellig Pharma, IntegriChain, Clinigen and Science Group and 2 more; 3 of its 7 listed competitors have raised funding.
Company details
Abelia, established in 2021 and currently in Dissolved stage, focuses on providing healthcare solutions, biopharma services, offering consulting services, and auditing and validation. Delivers validation, auditing, and consulting services tailored to the biopharma sector. Adapting to market demands with innovation and client-focused strategies.
- Headquarters Delhi, India
- Employees 1
- SectorsHealthcare
- Website abelia.in
- Legal Name Abelia Life Sciences Private Limited
- Date of Incorporation 13 Nov, 2020
- Jurisdiction New Delhi, Delhi, India
- Annual Revenue₹4.1 Lakh
FY 2021 · -76% YoY
- Net Profit₹2,717
FY 2021 · 1% margin
- EBITDA₹4,577
FY 2021 · 1% margin
- Employee Count1
Associated legal entities of Abelia
Abelia operates through Abelia Life Sciences Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2021) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Abelia Life Sciences Private Limited CIN U51909DL2020PTC373206 | Active | 13 Nov 2020 | New Delhi, Delhi | ₹0.0 Cr | – | 3 | View details |
Board of directors of Abelia Life Sciences Private Limited (Abelia)
Abelia Life Sciences Private Limited is the primary company behind Abelia. The board of Abelia Life Sciences Private Limited currently have 3 directors; the longest-serving is Sajal Kumar Tripathi, appointed in 2020.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Sajal Kumar Tripathi DIN 01520019 | Director | 13 Nov 2020 | 5 yrs 11 mo | Abelia Life Sciences Private Limited |
| Ravinder Kaur DIN 08960722 | Director | 13 Nov 2020 | 5 yrs 11 mo | Abelia Life Sciences Private Limited |
| Sudarshan Banerjee DIN 03060806 | Director | 13 Nov 2020 | 5 yrs 11 mo | Abelia Life Sciences Private Limited |
Financials of Abelia
Figures of Abelia Life Sciences Private Limited, the primary company behind Abelia, for FY 2021. Revenue was ₹4.1 Lakh (-76% year on year). Net profit was ₹2,717 (1% margin). EBITDA was ₹4,577 (1% margin). Revenue has grown at a compounded annual rate of -49% over three years and -22% over five years.
- ₹4.1 LakhRevenue · FY 2021 · -76% YoY
- ₹2,717Net profit · 1% margin
- ₹4,577EBITDA · 1% margin
- ₹1 LakhPaid-up capital
- -49%Revenue CAGR, 3 years
- -22%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Abelia Life Sciences Private Limited are on its company page.
Detailed financial statements for Abelia
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Abelia
Abelia has 7 listed competitors in our database, 3 of them funded. They include Indegene, Zuellig Pharma, IntegriChain, Clinigen and Science Group, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| indegene.com | 1998 | Princeton, United States | $220M | 350 | Suite solutions are provided for payers and healthcare providers. | |
| zuelligpharma.com | 1992 | Singapore | – | – | Healthcare access in Asia is enhanced by Zuellig Pharma. | |
| integrichain.com | 2005 | Philadelphia, United States | $2M | 320 | Inventory, order and customer relationship management solution for life science suppliers. | |
| clinigengroup.com | 2010 | Burton-on-trent, United Kingdom | – | – | Specialty medicines are supplied via clinical trials and access programs. | |
| sciencegroup.com | 1995 | Cambridge, United Kingdom | – | 431 | Technology-based consultancy and product development services are provided. | |
| clearviewhcp.com | 2008 | Newton, United States | – | 381 | Strategic consulting services are provided to life sciences companies. | |
| fabtechnologies.com | 2002 | Mumbai, India | $175,048 | 279 | Instruments for biotech, pharmaceutical, and biomedical sectors are manufactured. |
Detailed competitors of Abelia
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
10 companies that operate in the same segment as Abelia (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Drug discovery and development services are provided to biopharma sector. | 1993 | Hamburg, Hamburg, Germany | USD 25 M | USD 926.33 M | 4,830 | |
Drug discovery and development services for small molecules are provided. | 2003 | Beijing, China | USD 320 M | – | 476 | |
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
Pharmaceutical products for treating multiple diseases are provided. | 1849 | New York, New York, United States | USD 8 M | USD 266.99 M | 1,770 | |
Provider of laboratory tests for physicians | 1969 | Burlington, Vermont, United States | – | USD 13.95 B | 70,000 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Abelia
Abelia was founded in 2021.
Abelia is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.
Abelia has 1 employees.
The primary company behind Abelia, Abelia Life Sciences Private Limited, reported revenue of ₹4.1 Lakh for FY 2021, down 76% year on year.
Abelia, established in 2021 and currently in Dissolved stage, focuses on providing healthcare solutions, biopharma services, offering consulting services, and auditing and validation. Delivers validation, auditing, and consulting services tailored to the biopharma sector. Adapting to market demands with innovation and client-focused strategies.
Abelia's top competitors include Indegene, Zuellig Pharma and IntegriChain.
Abelia operates through Abelia Life Sciences Private Limited.
The legal entities of Abelia currently have 3 directors, including Sajal Kumar Tripathi, Ravinder Kaur, Sudarshan Banerjee.